|
⚲
|
| Keyboard |
| Colgan Erin
✚
|
|
|---|---|
| CIK # | 0001843563 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001843563] | |
| 4 | [0001843563] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Faeth Therapeutics Inc | |
| Colgan Erin |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-02-15 | Grant | 125,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2024-02-15 | Tax withheld | 3,627 | $0.79 | 2,865 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-02-15 | Grant | 94,128 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Tax withheld | 10,943 | $1.50 | 16,414 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2023-02-15 | Grant | 90,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Grant | 30,046 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Grant | 21,300 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2022-02-15 | Grant | 62,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2022-02-15 | Grant | 21,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2021-02-03 | Grant | 52,083 | $0.00 |